
Building successful biotechnology companies requires strong international partnerships alongside scientific innovation. Events that bring together biotechnology companies, pharmaceutical organizations, investors, and innovation stakeholders provide valuable opportunities to establish collaborations that accelerate the development and commercialization of new healthcare technologies.

Fetalix was recently featured in the Financial Times article “Portugal welcomes start-ups seeking scale”, which highlighted the country’s growing reputation as a hub for entrepreneurship, innovation, and technology development. The recognition places Fetalix among a group of companies contributing to the emergence of a dynamic ecosystem that supports the creation and growth of innovative ventures.

Fetalix participated in the Bridges4Health kick-off meeting, held on March 3, 2026, at Espaço Vita in Braga. The event marked the official launch of the Regional Smart Specialisation Platform (PREI) in Life and Health Sciences for Northern Portugal.